FDA advisers recommend using same strain for initial COVID vaccine and boosters

Illustration shows a test tube labelled "COVID-19 Test positive" and a vial labelled "VACCINE Coronavirus COVID-19\
A test tube labelled "COVID-19 Test Positive" and a vial labelled "VACCINE Coronavirus COVID-19" are seen in this illustration taken December 11, 2021. REUTERS/Dado Ruvic/Illustration

Jan 26 (Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of using the same coronavirus strain for the initial COVID-19 vaccine doses and the boosters, to simplify the vaccination regimen in the United States.

Reporting by Leroy Leo in Bengaluru; Editing by Sriraj Kalluvila

Our Standards: The Thomson Reuters Trust Principles.

Read Next